Quantiphi Strengthens AI Drug Discovery, Development Collaboration with Transcell Through Strategic Minority Investment

MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ — Quantiphi, an award-winning AI-first digital engineering company today announced it has acquired a strategic minority interest in leading stem cell-based biotech innovator Transcell, marking a milestone in AI-supported drug discovery in…